Cargando…

Surgical treatment in oligometastatic breast cancer

Metastatic breast cancer (MBC) management is based on systemic treatment (ST), while the local therapy role remains controversial. We present the case of a 36-year-old woman with a diagnosis of hormone receptor-positive and human epidermal growth factor receptor type 2-positive breast cancer and iso...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Catalina, Maiz, Cristóbal, Navarro, María Elena, Oddó, David, Sánchez, César, Bustos, Marisa, Camus, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592707/
https://www.ncbi.nlm.nih.gov/pubmed/31281428
http://dx.doi.org/10.3332/ecancer.2019.931
_version_ 1783429926315098112
author Vargas, Catalina
Maiz, Cristóbal
Navarro, María Elena
Oddó, David
Sánchez, César
Bustos, Marisa
Camus, Mauricio
author_facet Vargas, Catalina
Maiz, Cristóbal
Navarro, María Elena
Oddó, David
Sánchez, César
Bustos, Marisa
Camus, Mauricio
author_sort Vargas, Catalina
collection PubMed
description Metastatic breast cancer (MBC) management is based on systemic treatment (ST), while the local therapy role remains controversial. We present the case of a 36-year-old woman with a diagnosis of hormone receptor-positive and human epidermal growth factor receptor type 2-positive breast cancer and isolated sternal metastasis, who received neoadjuvant ST with complete remission and later primary tumour surgery. Oligometastatic patients are a subgroup of MBC that can benefit from aggressive local therapies, even with curative intent.
format Online
Article
Text
id pubmed-6592707
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-65927072019-07-05 Surgical treatment in oligometastatic breast cancer Vargas, Catalina Maiz, Cristóbal Navarro, María Elena Oddó, David Sánchez, César Bustos, Marisa Camus, Mauricio Ecancermedicalscience Case Report Metastatic breast cancer (MBC) management is based on systemic treatment (ST), while the local therapy role remains controversial. We present the case of a 36-year-old woman with a diagnosis of hormone receptor-positive and human epidermal growth factor receptor type 2-positive breast cancer and isolated sternal metastasis, who received neoadjuvant ST with complete remission and later primary tumour surgery. Oligometastatic patients are a subgroup of MBC that can benefit from aggressive local therapies, even with curative intent. Cancer Intelligence 2019-05-20 /pmc/articles/PMC6592707/ /pubmed/31281428 http://dx.doi.org/10.3332/ecancer.2019.931 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Vargas, Catalina
Maiz, Cristóbal
Navarro, María Elena
Oddó, David
Sánchez, César
Bustos, Marisa
Camus, Mauricio
Surgical treatment in oligometastatic breast cancer
title Surgical treatment in oligometastatic breast cancer
title_full Surgical treatment in oligometastatic breast cancer
title_fullStr Surgical treatment in oligometastatic breast cancer
title_full_unstemmed Surgical treatment in oligometastatic breast cancer
title_short Surgical treatment in oligometastatic breast cancer
title_sort surgical treatment in oligometastatic breast cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592707/
https://www.ncbi.nlm.nih.gov/pubmed/31281428
http://dx.doi.org/10.3332/ecancer.2019.931
work_keys_str_mv AT vargascatalina surgicaltreatmentinoligometastaticbreastcancer
AT maizcristobal surgicaltreatmentinoligometastaticbreastcancer
AT navarromariaelena surgicaltreatmentinoligometastaticbreastcancer
AT oddodavid surgicaltreatmentinoligometastaticbreastcancer
AT sanchezcesar surgicaltreatmentinoligometastaticbreastcancer
AT bustosmarisa surgicaltreatmentinoligometastaticbreastcancer
AT camusmauricio surgicaltreatmentinoligometastaticbreastcancer